
Sansure Biotech Inc. — Investor Relations & Filings
Sansure Biotech Inc. specializes in the development and manufacture of molecular diagnostic products and genetic testing solutions. The company utilizes proprietary technologies, such as the "One-tube" fast extraction method and advanced magnetic bead technology, to provide high-sensitivity PCR diagnostic kits. Its product portfolio covers a wide range of clinical applications, including infectious disease screening for hepatitis, respiratory infections, and sexually transmitted infections, as well as oncology and maternal health. Sansure also provides integrated laboratory automation systems, including nucleic acid extractors and real-time PCR instruments, designed to streamline clinical workflows and improve diagnostic efficiency for healthcare providers and research institutions globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 圣湘生物科技股份有限公司简式权益变动报告书 | 2022-03-14 | Chinese | |
| 圣湘生物科技股份有限公司关于持股5%以上股东权益变动的提示性公告 | 2022-03-14 | Chinese | |
| 西部证券股份有限公司关于圣湘生物科技股份有限公司2022年开展外汇套期保值业务的核查意见 | 2022-03-14 | Chinese | |
| 圣湘生物科技股份有限公司关于开展外汇套期保值业务的公告 | 2022-03-14 | Chinese | |
| 圣湘生物科技股份有限公司关于持股5%以上股东权益变动达到1%的提示性公告 | 2022-03-11 | Chinese | |
| 圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告 | 2022-03-08 | Chinese |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 44478080 | 圣湘生物科技股份有限公司简式权益变动报告书 | 2022-03-14 | Chinese | ||
| 44478073 | 圣湘生物科技股份有限公司关于持股5%以上股东权益变动的提示性公告 | 2022-03-14 | Chinese | ||
| 44478063 | 西部证券股份有限公司关于圣湘生物科技股份有限公司2022年开展外汇套期保值业务的核查意见 | 2022-03-14 | Chinese | ||
| 44478055 | 圣湘生物科技股份有限公司关于开展外汇套期保值业务的公告 | 2022-03-14 | Chinese | ||
| 44478044 | 圣湘生物科技股份有限公司关于持股5%以上股东权益变动达到1%的提示性公告 | 2022-03-11 | Chinese | ||
| 44478031 | 圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证的公告 | 2022-03-08 | Chinese | ||
| 44478024 | 圣湘生物科技股份有限公司关于持股5%以上股东权益变动达到1%的提示性公告 | 2022-03-03 | Chinese | ||
| 44478016 | 圣湘生物科技股份有限公司2021年度业绩快报公告 | 2022-02-24 | Chinese | ||
| 44478009 | 圣湘生物科技股份有限公司5%以上股东终止减持股份计划暨减持股份结果公告 | 2022-02-18 | Chinese | ||
| 44478001 | 圣湘生物科技股份有限公司关于股份回购实施结果的公告 | 2022-02-08 | Chinese | ||
| 44477994 | 圣湘生物科技股份有限公司持股5%以上股东集中竞价减持股份计划公告 | 2022-01-28 | Chinese | ||
| 44477982 | 圣湘生物科技股份有限公司关于实际控制人兼董事长增持股份进展的公告 | 2022-01-21 | Chinese | ||
| 44477974 | 圣湘生物科技股份有限公司股东减持股份时间过半的进展公告 | 2022-01-11 | Chinese | ||
| 44477954 | 圣湘生物科技股份有限公司关于自愿披露相关产品取得医疗器械注册证及法国卫生部备案许可的公告 | 2022-01-06 | Chinese | ||
| 44477948 | 圣湘生物科技股份有限公司关于公司高级管理人员辞职的公告 | 2022-01-05 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sansure Biotech Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58306/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58306 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58306 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58306 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58306}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sansure Biotech Inc. (id: 58306)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.